http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107515270-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-90
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-90
filingDate 2017-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107515270-B
titleOfInvention Quality control method of ganoderma lucidum two-dimensional methionine capsule
abstract The invention discloses a quality control method of a ganoderma lucidum two-dimensional methionine capsule, which is improved aiming at the problems of the existing ganoderma lucidum two-dimensional methionine capsule related preparation quality detection method, and mainly adds thin layer identification, content uniformity inspection and dissolution rate inspection of ganoderma lucidum, and adopts an HPLC method to perform content determination of three components. The quality control method provided by the invention is reasonable in design, accurate and reliable, strong in specificity and simple in operation, establishes a new quality control standard of the ganoderma lucidum two-dimensional methionine capsule, can help to effectively control the medicine quality and improve the quality level of the ganoderma lucidum two-dimensional methionine capsule in the production, circulation and use links, ensures the controllable production process, ensures the safe clinical use, and provides reliable guarantee for the stable and definite curative effect of the product.
priorityDate 2017-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5057224-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03069338-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452764334
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407631466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87064819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21584169
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537510
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID493570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415783739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551021
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9543525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447499106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553045
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID284

Total number of triples: 38.